ELVN — Enliven Therapeutics Share News
0.000.00%
Last trade - 00:00Brief: Enliven Therapeutics Inc Files For Mixed Shelf Of Up To $400 Mln – SEC Filing
Enliven Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Enliven Therapeutics Reports First Quarter 2023 Financial Results
Enliven Therapeutics Inc expected to post a loss of 63 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Terns Pharma, Rivian, Intel, Micron
U.S. STOCKS ON THE MOVE-Nikola, Cintas, Seagate
U.S. STOCKS ON THE MOVE-N-Able Inc, major U.S. banks, Lululemon Athletica Inc
Jefferies initiates Enliven with 'buy' on cancer therapies prospects
U.S. RESEARCH ROUNDUP- Enliven Therapeutics, Lululemon Athletica, Walgreens
Imara Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Arix Bioscience Says Portfolio Co Imara Announces Merger Deal With Enliven Therapeutics
Imara Inc gains on deal to merge with private firm Enliven
Brief: Enliven Therapeutics And Imara Announce Merger Agreement
U.S. STOCKS ON THE MOVE-Pinterest, Aemetis, Walmart
U.S. STOCKS ON THE MOVE-Twitter, ChargePoint, IMAX
U.S. STOCKS ON THE MOVE-Biophytis, Gold miners, Imara
Imara jumps on sale of assets
Brief: Imara Inc - Following The Asset Sale, Co Expects To Continue To Evaluate Its Strategic Alternatives
Brief: Imara Inc - On Sept 6, Co Entered Into An Asset Purchase Agreement With Cardurion Pharmaceuticals